AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets
27 juil. 2020 07h30 HE
|
AMAG Pharmaceuticals, Inc.
Vyleesi® returned to Palatin Technologies Company focuses on optimizing marketed assets and development of its innovative pipeline WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- AMAG...
AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New Zealand
23 juil. 2020 07h13 HE
|
AMAG Pharmaceuticals, Inc.
Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties ...
AMAG Announces Presentation of Ciraparantag Data at the International Society on Thrombosis and Haemostasis
12 juil. 2020 08h30 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., July 12, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the poster presentation of data from two Phase 2 randomized, placebo-controlled, dose...
AMAG Pharmaceuticals Announces Leadership Changes
11 juin 2020 07h00 HE
|
AMAG Pharmaceuticals, Inc.
Company initiates CFO & COO succession plan; appoints internal seasoned finance leader as interim CFO Anthony Casciano assumes expanded role as AMAG’s COO WALTHAM, Mass., June ...
AMAG Pharmaceuticals to Participate in Jefferies Virtual Global Healthcare Conference
27 mai 2020 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., May 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will participate at the Jefferies Virtual Global Healthcare Conference on...
AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million
21 mai 2020 17h00 HE
|
AMAG Pharmaceuticals, Inc.
Transaction allows AMAG to advance its strategic focus on Feraheme, Makena and its pipeline, consistent with previously announced plans Millicent Pharma uniquely positioned to drive revenue growth of...
AMAG Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update
11 mai 2020 07h00 HE
|
AMAG Pharmaceuticals, Inc.
Feraheme® (ferumoxytol injection) posts strong first quarter results Company implements a workforce reduction of approximately 30 percent or 140 positions, as part of a planned decrease in operating...
AMAG Pharmaceuticals Appoints Scott Myers as President and Chief Executive Officer
28 avr. 2020 07h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its Board of Directors has appointed Scott Myers as AMAG’s President and Chief...
AMAG Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast on Monday, May 11, 2020
27 avr. 2020 16h30 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its first quarter 2020 financial results will be released on Monday, May 11, 2020...
AMAG Pharmaceuticals Provides COVID-19 Company Update
16 avr. 2020 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today provided an update regarding the potential impact of COVID-19 on the company. AMAG is committed to...